FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023774600> ?p ?o ?g. }

• W2023774600 endingPage "222" @default.
• W2023774600 startingPage "217" @default.
• W2023774600 abstract "Purpose To evaluate the efficacy of methotrexate (MTX) and the effect of its withdrawal on relapse rate of uveitis associated with juvenile idiopathic arthritis (JIA). Design Retrospective case series. Methods Data of 22 pediatric JIA patients who were being treated with MTX for active uveitis were studied retrospectively. Relapse rate after the withdrawal of MTX was established. Anterior chamber (AC) inflammation, topical steroid use during the first year of MTX treatment, and associations of relapses after the withdrawal were evaluated statistically. Duration of MTX treatment and its withdrawal was determined individually in collaboration with a rheumatologist with an intention to continue the treatment for at least 1 year and to withdraw in case of inactivity of uveitis and arthritis. Inactivity of uveitis was defined as the presence of ≤0.5+ cells in the AC. Results Eighteen patients (18/22; 82%) showed improvement of their uveitis with a significant decrease in activity of AC inflammation after a minimal period of 3 months of MTX treatment. A topical steroid–sparing effect was observed when MTX was administered for a period of 3 to 9 months. MTX was discontinued because of inactive uveitis in 13 patients. In 9 patients (8/13; 69%) a relapse of uveitis was observed after a mean time of 7.5 months (± SD 7.3). Six patients (6/13; 46%) had a relapse within the first year after the withdrawal. Relapse-free survival after withdrawal of MTX was significantly longer in patients who had been treated with MTX for more than 3 years (P = .009), children who were older than 8 years at the moment of withdrawal (P = .003), and patients who had an inactivity of uveitis of longer than 2 years before withdrawal of MTX (P = .033). Longer inactivity under MTX therapy was independently protective for relapses after the withdrawal (hazard ratio = 0.07; 95% confidence interval 0.01-0.86; P = .038), which means that 1-year increase of duration of inactive uveitis before the withdrawal of MTX results in a decrease of hazard for new relapse of 93%. Conclusions A high number of patients with inactive uveitis relapse quickly after the withdrawal of MTX. Our results suggest that a longer period of inactivity prior to withdrawal and a longer treatment period with MTX reduce the chance of relapse after withdrawal. To evaluate the efficacy of methotrexate (MTX) and the effect of its withdrawal on relapse rate of uveitis associated with juvenile idiopathic arthritis (JIA). Retrospective case series. Data of 22 pediatric JIA patients who were being treated with MTX for active uveitis were studied retrospectively. Relapse rate after the withdrawal of MTX was established. Anterior chamber (AC) inflammation, topical steroid use during the first year of MTX treatment, and associations of relapses after the withdrawal were evaluated statistically. Duration of MTX treatment and its withdrawal was determined individually in collaboration with a rheumatologist with an intention to continue the treatment for at least 1 year and to withdraw in case of inactivity of uveitis and arthritis. Inactivity of uveitis was defined as the presence of ≤0.5+ cells in the AC. Eighteen patients (18/22; 82%) showed improvement of their uveitis with a significant decrease in activity of AC inflammation after a minimal period of 3 months of MTX treatment. A topical steroid–sparing effect was observed when MTX was administered for a period of 3 to 9 months. MTX was discontinued because of inactive uveitis in 13 patients. In 9 patients (8/13; 69%) a relapse of uveitis was observed after a mean time of 7.5 months (± SD 7.3). Six patients (6/13; 46%) had a relapse within the first year after the withdrawal. Relapse-free survival after withdrawal of MTX was significantly longer in patients who had been treated with MTX for more than 3 years (P = .009), children who were older than 8 years at the moment of withdrawal (P = .003), and patients who had an inactivity of uveitis of longer than 2 years before withdrawal of MTX (P = .033). Longer inactivity under MTX therapy was independently protective for relapses after the withdrawal (hazard ratio = 0.07; 95% confidence interval 0.01-0.86; P = .038), which means that 1-year increase of duration of inactive uveitis before the withdrawal of MTX results in a decrease of hazard for new relapse of 93%. A high number of patients with inactive uveitis relapse quickly after the withdrawal of MTX. Our results suggest that a longer period of inactivity prior to withdrawal and a longer treatment period with MTX reduce the chance of relapse after withdrawal." @default.
• W2023774600 created "2016-06-24" @default.
• W2023774600 creator A5039022052 @default.
• W2023774600 creator A5057554255 @default.
• W2023774600 creator A5080508360 @default.
• W2023774600 creator A5081084218 @default.
• W2023774600 date "2011-02-01" @default.
• W2023774600 modified "2023-10-09" @default.
• W2023774600 title "Relapse Rate of Uveitis Post-Methotrexate Treatment in Juvenile Idiopathic Arthritis" @default.
• W2023774600 cites W1977063092 @default.
• W2023774600 cites W2002804672 @default.
• W2023774600 cites W2014114774 @default.
• W2023774600 cites W2036644487 @default.
• W2023774600 cites W2046422595 @default.
• W2023774600 cites W2058828388 @default.
• W2023774600 cites W2062170681 @default.
• W2023774600 cites W2082186503 @default.
• W2023774600 cites W2097613586 @default.
• W2023774600 cites W2098495975 @default.
• W2023774600 cites W2100564890 @default.
• W2023774600 cites W2127133939 @default.
• W2023774600 cites W2139499737 @default.
• W2023774600 cites W2142555697 @default.
• W2023774600 cites W2154980334 @default.
• W2023774600 cites W2342174771 @default.
• W2023774600 doi "https://doi.org/10.1016/j.ajo.2010.08.021" @default.
• W2023774600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21145533" @default.
• W2023774600 hasPublicationYear "2011" @default.
• W2023774600 type Work @default.
• W2023774600 sameAs 2023774600 @default.
• W2023774600 citedByCount "92" @default.
• W2023774600 countsByYear W20237746002012 @default.
• W2023774600 countsByYear W20237746002013 @default.
• W2023774600 countsByYear W20237746002014 @default.
• W2023774600 countsByYear W20237746002015 @default.
• W2023774600 countsByYear W20237746002016 @default.
• W2023774600 countsByYear W20237746002017 @default.
• W2023774600 countsByYear W20237746002018 @default.
• W2023774600 countsByYear W20237746002019 @default.
• W2023774600 countsByYear W20237746002020 @default.
• W2023774600 countsByYear W20237746002021 @default.
• W2023774600 countsByYear W20237746002022 @default.
• W2023774600 countsByYear W20237746002023 @default.
• W2023774600 crossrefType "journal-article" @default.
• W2023774600 hasAuthorship W2023774600A5039022052 @default.
• W2023774600 hasAuthorship W2023774600A5057554255 @default.
• W2023774600 hasAuthorship W2023774600A5080508360 @default.
• W2023774600 hasAuthorship W2023774600A5081084218 @default.
• W2023774600 hasConcept C115961737 @default.
• W2023774600 hasConcept C118487528 @default.
• W2023774600 hasConcept C126322002 @default.
• W2023774600 hasConcept C141071460 @default.
• W2023774600 hasConcept C167135981 @default.
• W2023774600 hasConcept C2776194053 @default.
• W2023774600 hasConcept C2776804153 @default.
• W2023774600 hasConcept C2777077863 @default.
• W2023774600 hasConcept C2781059491 @default.
• W2023774600 hasConcept C54355233 @default.
• W2023774600 hasConcept C71924100 @default.
• W2023774600 hasConcept C86803240 @default.
• W2023774600 hasConcept C90924648 @default.
• W2023774600 hasConceptScore W2023774600C115961737 @default.
• W2023774600 hasConceptScore W2023774600C118487528 @default.
• W2023774600 hasConceptScore W2023774600C126322002 @default.
• W2023774600 hasConceptScore W2023774600C141071460 @default.
• W2023774600 hasConceptScore W2023774600C167135981 @default.
• W2023774600 hasConceptScore W2023774600C2776194053 @default.
• W2023774600 hasConceptScore W2023774600C2776804153 @default.
• W2023774600 hasConceptScore W2023774600C2777077863 @default.
• W2023774600 hasConceptScore W2023774600C2781059491 @default.
• W2023774600 hasConceptScore W2023774600C54355233 @default.
• W2023774600 hasConceptScore W2023774600C71924100 @default.
• W2023774600 hasConceptScore W2023774600C86803240 @default.
• W2023774600 hasConceptScore W2023774600C90924648 @default.
• W2023774600 hasFunder F4320322886 @default.
• W2023774600 hasFunder F4320326349 @default.
• W2023774600 hasIssue "2" @default.
• W2023774600 hasLocation W20237746001 @default.
• W2023774600 hasLocation W20237746002 @default.
• W2023774600 hasOpenAccess W2023774600 @default.
• W2023774600 hasPrimaryLocation W20237746001 @default.
• W2023774600 hasRelatedWork W2023774600 @default.
• W2023774600 hasRelatedWork W2086327687 @default.
• W2023774600 hasRelatedWork W2093811051 @default.
• W2023774600 hasRelatedWork W2313698566 @default.
• W2023774600 hasRelatedWork W2601106257 @default.
• W2023774600 hasRelatedWork W2789337934 @default.
• W2023774600 hasRelatedWork W2992308296 @default.
• W2023774600 hasRelatedWork W3212659794 @default.
• W2023774600 hasRelatedWork W4249241068 @default.
• W2023774600 hasRelatedWork W923643347 @default.
• W2023774600 hasVolume "151" @default.
• W2023774600 isParatext "false" @default.
• W2023774600 isRetracted "false" @default.
• W2023774600 magId "2023774600" @default.
• W2023774600 workType "article" @default.